publication venue for Development of a neuroimaging biomarker of the pro-coagulant state in Alzheimer's disease: The BioClotAD project. 42. 2022 Assessment of motion and model bias on the detection of dopamine response to behavioral challenge. 42:1309-1321. 2022 Cerebral blood flow is an earlier indicator of perfusion abnormalities than cerebral blood volume in Alzheimer's disease. 34:654-659. 2014